Introgen Announces New Clinical Data Confirming ADVEXIN(R … - netPR.pl (komunikaty prasowe)
Introgen Announces New Clinical Data Confirming ADVEXIN(R …netPR.pl (komunikaty prasowe), Poland - Dec 11, 2006The application will be for the use of ADVEXIN p53 therapy for the treatment of Li-Fraumeni Syndrome (LFS). LFS is a genetic disorder characterized by …
Read full story